Magnetic resonance imaging-guided versus computed tomography-guided stereotactic body radiotherapy for prostate cancer (MIRAGE): Interim analysis of a phase III randomized trial.Amar U. Kishan, Michael L. Steinberg, Maria Casado et al.|Journal of Clinical Oncology|2022Cited by 30